Articles

Permanent URI for this collection

https://testres.nu.edu.kz/handle/123456789/2689

Browse

Browsing Articles by Author "A., Almadiyeva"

Now showing 1 - 1 of 1
  • No Thumbnail Available
    ItemMetadata only
    PIN28 Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan
    (2013-11-01) Almadiyeva, A.; Kostyuk, A.; Nurgozhin, T.; A., Almadiyeva
    Currently, 23 thousand people (registered) are suffering from Hepatitis C in Germany (more 60% genotype 1). TThe licensing of direct-acting antivirals heralds a new era in the treatment of hepatitis C virus (HCV) genotype 1. Clinical studies showed a significant increase in sustained virological response rates from 38-46% to 63-79%. This study was to evaluate the cost-effectiveness of newly introduced triple therapy with Telaprevir (TVR+PR) compared to dual therapy (PR) for the treatment of genotype 1 hepatitis C virus (HCV) infection in previously untreated patients.